Diagnostics

The draft guidelines include language on reporting biomarkers predicting therapy response or resistance, liquid biopsy, and mutational signatures like TMB, MSI, and HRD.

The companies will codevelop NGS workflows that integrate NEBNext reagents with the Callisto automation platform.

Held this week in Toronto, the meeting showcased areas like spatial biology, single-cell analysis, and population health as well as new and forthcoming commercial releases.

The Class II medical device registration allows the Matrix Neo automated platform for single-cell sample processing to be deployed for clinical use in China.

The optical genome mapping company, which underwent a major restructuring last year, hopes to move beyond the cytogenetics market with its instruments and software.